Medi-Caps
Medi-Caps Share Price Chart
Medi-Caps last traded at ₹25.00 (2026-10-13). Over the past month the stock moved -27.7%, three months the stock moved -10.7%, year the stock moved -37.1%. Its closing range over 52 weeks is ₹22.18 – ₹39.00, with the latest close 35.9% below the high.
Closing prices up to 2026-10-13.
About Medi-Caps
Incorporated in 1983, Medi-Caps Ltd is in the business of real estate and pharmaceuticals[1]
Business Overview:[1] MCL operates in real estate as a parent company and pharma division through its wholly owned subsidiary. The company entered the real estate segment for city centric developments by way of Land acquisition and developing premium residential and commercial properties. It has almost completed its first project Medicaps Business Park and also sold ~50% of shops in the project
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Medi-Caps reported sales of ₹2.79 crore (+3.7%) and net profit of ₹-2.23 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 2.79 | -1.83 | -65.59 | -2.23 | -1.79 |
| Mar 2026 | 3.45 | -2.06 | -59.71 | 3.04 | 2.44 |
| Dec 2025 | 4.30 | -1.06 | -24.65 | -0.77 | -0.62 |
| Sep 2025 | 2.02 | -2.91 | -144.06 | -1.82 | -1.46 |
| Jun 2025 | 2.69 | -3.38 | -125.65 | -3.49 | -2.80 |
| Mar 2025 | 6.97 | -0.23 | -3.30 | 1.72 | 1.38 |
| Dec 2024 | 4.02 | -1.78 | -44.28 | -2.05 | -1.64 |
| Sep 2024 | 8.29 | 0.45 | 5.43 | 0.31 | 0.25 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +37.5% | -43.1% | -11.4% | -56.6% | -75.6% | +7.0% | -50.5% | +3.7% |
| Operating profit growth | -10.0% | -354.3% | – | – | -746.7% | – | – | – |
| Net profit growth | +158.3% | – | – | – | -687.1% | – | +76.7% | – |
| EPS growth | +150.0% | – | – | – | -684.0% | – | +76.8% | – |
| OPM % | 5.4% | -44.3% | -3.3% | -125.7% | -144.1% | -24.7% | -59.7% | -65.6% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Medi-Caps reported sales of ₹12.45 crore (-51.1%) and net profit of ₹-3.04 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 12.45 | -9.42 | -75.66 | -3.04 | -2.44 |
| Mar 2025 | 25.47 | -1.83 | -7.18 | -0.57 | -0.46 |
| Mar 2024 | 27.35 | 0.00 | 0.00 | -2.24 | -1.80 |
| Mar 2023 | 49.37 | 5.19 | 10.51 | 1.76 | 1.41 |
| Mar 2022 | 69.87 | 10.07 | 14.41 | 10.08 | 8.08 |
| Mar 2021 | 58.72 | 12.28 | 20.91 | 11.13 | 8.93 |
| Mar 2020 | 43.05 | -6.75 | -15.68 | -5.85 | -4.69 |
| Mar 2019 | 51.79 | 4.72 | 9.11 | 5.39 | 4.32 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -3.6% | -16.9% | +36.4% | +19.0% | -29.3% | -44.6% | -6.9% | -51.1% |
| Operating profit growth | +117.5% | -243.0% | – | -18.0% | -48.5% | -100.0% | – | – |
| Net profit growth | +368.7% | -208.5% | – | -9.4% | -82.5% | -227.3% | – | – |
| EPS growth | +369.6% | -208.6% | – | -9.5% | -82.5% | -227.7% | – | – |
| OPM % | 9.1% | -15.7% | 20.9% | 14.4% | 10.5% | 0.0% | -7.2% | -75.7% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Medi-Caps.
Get Free AI Stock Analysis FREE →Latest News
-
Medi-Caps reports Profit after tax of Rs -5.90 Mln, in the June 2026 quarter
Frequently Asked Questions
What is the share price of Medi-Caps today?
Medi-Caps shares were last quoted at ₹25.00 (-2.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Medi-Caps?
Medi-Caps has a price-to-earnings (P/E) ratio of -97.15 and a price-to-book (P/B) ratio of 0.30. The industry P/E is 52.82.
What is the 52-week high and low of Medi-Caps?
The 52-week high of Medi-Caps is ₹44.70 and the 52-week low is ₹21.00.
What is the market cap of Medi-Caps?
The market capitalisation of Medi-Caps is about ₹32.71 crore.
How did Medi-Caps perform in its latest quarterly results?
In the latest quarter (Jun 2026), Medi-Caps reported sales of ₹2.79 crore (+3.7%) and net profit of ₹-2.23 crore, compared with the same quarter last year.
Is Medi-Caps a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Medi-Caps has a 3-year ROE of -2.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Medi-Caps?
Promoters hold about 51.44% of Medi-Caps.
Which sector does Medi-Caps belong to?
Medi-Caps belongs to the Pharmaceuticals & Drugs sector.